Venus Concept, a Toronto, ON, Canada-based medical aesthetic company, received a $10M minority investment.
Longitude Capital, a private investment firm focused on venture growth investments in medical technology and drug development companies, provided the funding.
The company intends to use the proceeds to further its investments in research and development, strengthen sales operations in growing markets, and implement its subscription based business model worldwide.
Led by Domenic Serafino, CEO, Venus Concept designs and manufactures comprehensive aesthetic devices for non surgical circumferential reduction, wrinkle reduction, cellulite reduction, and skin tightening under the brands Venus Swan, Venus Freeze, Venus Legacy, Venus Viva, and Venus Skin.
FinSMEs
22/05/2014